Corpus 1,277 assessed · 1,178 scored · 644 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 4.8k

Explore

Filters: Shenzhen University Health Science Center ✕ Oncology ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer. PMID 41369820	Discov Oncol	2025	59	L1 59/100
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients. PMID 35425715	Front Oncol	2022	53	L1 53/100

Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer.

PMID 41369820 · Discov Oncol · 2025

L1 59/100

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.

PMID 35425715 · Front Oncol · 2022

L1 53/100